Naomi Kresge
Bloomberg
Germany
Contact Naomi
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Naomi:
Nestlé’s $6,000 Peanut Allergy Pill Has Been a Dud
It spent $2.6 billion developing Palforzia, but the treatment regimen proved too cumbersome for many prospective patients. → Read More
WHO Wants More Data From China as Omicron Drives Covid Surge
Two known omicron subvariants are driving the vast majority of infections as Covid-19 surges through China, the World Health Organization said on Wednesday, repeating a call for more transparency as the country grapples with the end of its Covid Zero policy. The WHO wants rapid, regular and reliable data on hospitalizations, as well as more comprehensive real-time viral sequencing, WHO… → Read More
From Bedrooms to Kitchens, Europe Ponders How Cold Is Too Cold
With fuel in short supply, thermostats will be turned down this winter. From lap cats to quilts to brisk walks, here’s how to make the best of a bad situation. → Read More
A Free Period-Tracking App That Doesn’t Sell Your Data
Drip, from a collective of coders in Berlin, says privacy should be paramount for services that help women predict menstruation and fertility. → Read More
Moderna CEO Bancel Says He’ll Give Most of His Money Away
Moderna CEO Stephane Bancel has an estimated net worth of $4.1 billion. → Read More
Putin’s War Hobbles Work on Covid Pill in Lab Near Front Lines
Based in Kyiv, Enamine has become a key player in global drug research. → Read More
How Safe Is Flying With the Omicron Variant Surging?
How safe is it to fly in the age of Covid-19? The question has been the subject of debate for almost two years. The airline industry has argued that the risk to passengers is very low; independent researchers have tended to say that it’s not high, while stipulating that it’s impossible to assess with real accuracy. Whatever the odds of getting infected by the coronavirus on a plane, they’ve… → Read More
Omicron Gets Around Previous Covid Infection, Study Warns
A previous Covid-19 recovery provides little shield against infection with the omicron variant, a research team from Imperial College London showed in a large study that underlines the importance of booster shots. → Read More
Omicron Threat May Be Countered With Extra Dose of Vaccine
The earliest studies on omicron are in and the glimpse they’re providing is cautiously optimistic: while vaccines like the one made by Pfizer Inc. and BioNTech SE may be less powerful against the new variant, protection can be fortified with boosters. → Read More
Germany Faces ‘Long Road Ahead’ in Covid Battle, Expert Warns
Germany has a long battle ahead against the Covid-19 pandemic, a top health official warned, with pressure set to increase on intensive-care units even as infections show signs of peaking. → Read More
Germany to Halt Wage Subsidies for Unvaccinated Who Miss Work
Germany will stop subsidizing lost wages for unvaccinated people who miss work due to Covid-19 quarantine, the latest in a series of increasingly strict tactics to prod people to get their shots. → Read More
EU Authorities Say No Urgent Need For Covid Booster Shots
European Union health authorities said there’s no urgent need for widespread use of Covid-19 vaccine booster shots, though people with weakened immune systems should be offered a third dose. → Read More
Covid Vaccines Are Less Effective Against Delta, Large Study Finds
Vaccines against Covid-19 are less effective against the delta variant, a large U.K. study showed in results that may fuel a push for booster shots for fully vaccinated people. → Read More
Angela Merkel Makes Urgent Appeal for Germans to Get Covid-19 Shots
German Chancellor Angela Merkel reinforced the government’s urgent appeal for people to get vaccinated against Covid-19, saying the inoculation campaign will be the deciding factor for the future course of the pandemic. → Read More
A New Wave of Vaccines Is Coming, and They’re Not All Also-Rans
Dozens of companies are developing shots—and some will likely succeed as Covid lingers. → Read More
Roche’s Covid Pill Tests Delayed by U.K.’s Swift Vaccine Drive
Roche Holding AG has run into a speed bump as it seeks to rush a pill for Covid-19 to the market: The U.K.’s aggressive vaccine drive has made it harder to find sick people to test it on. → Read More
Pfizer, BioNTech Seek EU Clearance for Covid-19 Vaccine
Pfizer Inc. and partner BioNTech SE sought regulatory clearance for their Covid-19 vaccine in Europe, putting the shot on track for a potential approval there before the end of the year. The formal application submitted on Monday caps a rolling review process that started on Oct. → Read More
How Safe Is Flying in the Age of Coronavirus?
How safe is it to fly? This remains a troubling question. The hopes of airlines for a rebound in travel after an initial collapse ran up against a resurgence of the coronavirus around the world in late 2020. Would-be passengers continue to worry about being stuck in a cabin for an extended time with possibly infectious strangers. The evidence shows the risks aren’t negligible. → Read More
Covid Vaccine Frontrunners Will Soon See Their Moment of Truth
(Bloomberg) -- Drugmakers made big promises for a quick turnaround on coronavirus vaccines. The moment of truth for the front-runners is coming as soon as this month. → Read More
Moderna’s Coronavirus Treatment Transforms Body Into Vaccine-Making Machine
The U.S. company and its German rival BioNTech plan to use RNA as a messenger inside cells to produce an immune reaction. The advance could upend vaccine development long after the pandemic. → Read More